Fallopian Tube Neoplasms

31 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Fallopian Tube Neoplasms
Treatment and conditionWhere it standsTrials
[11C]AZ1419 3391 + Palacaparib for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
[11C]AZ1419 3391 + Palacaparib + Temozolomide for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
AVB-001 (Dose Escalation Phase) + AVB-001 (Dose Expansion Phase) for fallopian tube neoplasmsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Bevacizumab + nivolumab for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bevacizumab + nivolumab + rucaparib for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] + CEMIPLIMAB + Ubletamig for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ceralasertib + Olaparib for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
IMNN-001 for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) for fallopian tube neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Losartan + Paclitaxel for fallopian tube neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Biospecimen Collection + Computed Tomography + pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine + Carboplatin for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mirvetuximab Soravtansine for fallopian tube neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Olaparib for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Palacaparib for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Palacaparib + Datopotamab Deruxtecan for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Palacaparib + Temozolomide for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pegylated liposomal doxorubicin + TOPOTECAN + Paclitaxel for fallopian tube neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Questionnaire Administration + Dordaviprone + Paclitaxel for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Relacorilant + nab-paclitaxel for fallopian tube neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
TRASTUZUMAB DERUXTECAN + Palacaparib for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tremelimumab for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
TREMELIMUMAB + Olaparib for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tretinoin for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBAMATAMAB + Ubletamig + SARILUMAB for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Upifitimab rilsodotin for fallopian tube neoplasmsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Utidelone capsule 35mg/m2/d BID for fallopian tube neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Utidelone capsule 40mg/m2/d BID for fallopian tube neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Utidelone capsule 50mg/m2/d BID for fallopian tube neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Utidelone capsule 75mg/m2/d QD for fallopian tube neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vudalimab for fallopian tube neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1